Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 427,740 | 501,313 | 496,304 | 392,604 | 353,829 |
| Marketable Securities | 417,891 | 322,092 | 331,487 | 338,465 | 328,157 |
| Receivables | 138,662 | 127,022 | 127,425 | 129,633 | 111,439 |
| Inventories | 45,556 | 42,646 | 40,475 | 37,632 | 31,041 |
| Income taxes - deferred | 15,308 | 10,642 | 14,006 | 10,103 | N/A |
| TOTAL | $1,059,648 | $1,019,741 | $1,024,602 | $925,650 | $841,347 |
| Non-Current Assets | |||||
| PPE Net | 153,775 | 153,582 | 150,776 | 148,871 | 150,388 |
| Investments And Advances | 257,291 | 193,485 | 128,066 | 133,113 | 138,807 |
| Other Non-Current Assets | 29,934 | 30,159 | 30,350 | 32,460 | 7,852 |
| TOTAL | $441,000 | $377,226 | $309,192 | $314,444 | $297,047 |
| Total Assets | $1,500,648 | $1,396,967 | $1,333,794 | $1,240,094 | $1,138,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,544 | 4,089 | 3,238 | 2,097 | 7,124 |
| Accrued Expenses | 119,045 | 101,913 | 97,933 | 87,473 | 78,155 |
| TOTAL | $127,397 | $107,802 | $102,942 | $91,268 | $86,896 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14,125 | 12,436 | 11,292 | 10,950 | 10,851 |
| TOTAL | $14,125 | $12,436 | $11,292 | $10,950 | $10,851 |
| Total Liabilities | $141,522 | $120,238 | $114,234 | $102,218 | $97,747 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,599 | 29,480 | 29,232 | 28,998 | 28,943 |
| Retained earnings | 134,863 | 80,095 | 24,163 | -27,237 | -106,602 |
| Other shareholders' equity | -4,335 | -1,623 | 1,136 | 1,100 | 1,157 |
| TOTAL | $1,359,126 | $1,276,729 | $1,219,560 | $1,137,876 | $1,040,647 |
| Total Liabilities And Equity | $1,500,648 | $1,396,967 | $1,333,794 | $1,240,094 | $1,138,394 |